1. Home
  2. EOLS vs LMB Comparison

EOLS vs LMB Comparison

Compare EOLS & LMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evolus Inc.

EOLS

Evolus Inc.

N/A

Current Price

$8.00

Market Cap

550.9M

Sector

Health Care

ML Signal

N/A

Logo Limbach Holdings Inc.

LMB

Limbach Holdings Inc.

N/A

Current Price

$51.93

Market Cap

579.3M

ML Signal

N/A

Company Overview

Basic Information
Metric
EOLS
LMB
Founded
2012
1901
Country
United States
United States
Employees
N/A
1400
Industry
Biotechnology: Pharmaceutical Preparations
Engineering & Construction
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
550.9M
579.3M
IPO Year
2018
2014

Fundamental Metrics

Financial Performance
Metric
EOLS
LMB
Price
$8.00
$51.93
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
3
Target Price
$15.50
$116.67
AVG Volume (30 Days)
912.2K
412.2K
Earning Date
05-04-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
1.23
25.68
EPS
N/A
0.76
Revenue
$297,176,000.00
$646,804,000.00
Revenue This Year
$13.27
$15.96
Revenue Next Year
$17.62
$5.90
P/E Ratio
N/A
$66.47
Revenue Growth
11.61
24.68
52 Week Low
$3.86
$40.74
52 Week High
$9.31
$114.95

Technical Indicators

Market Signals
Indicator
EOLS
LMB
Relative Strength Index (RSI) 45.18 50.79
Support Level $5.78 $40.74
Resistance Level $8.43 $84.79
Average True Range (ATR) 0.36 2.15
MACD -0.21 1.69
Stochastic Oscillator 18.60 84.17

Price Performance

Historical Comparison
EOLS
LMB

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.

About LMB Limbach Holdings Inc.

Limbach Holdings Inc is a building systems solutions firm that designs, delivers, and maintains mechanical (heating, ventilation, and air conditioning), electrical, plumbing, and controls (MEPC) systems. The Company partners with owners and operators of facilities across healthcare, industrial and manufacturing, data centers, life sciences, higher education, and cultural and entertainment markets. It operates through two segments: Owner Direct Relationships (ODR), which generates maximum revenue and includes owner direct projects, maintenance, and service on MEPC systems; and General Contractor Relationships (GCR), which manages new construction or renovation projects involving MEPC systems awarded by general contractors or construction managers.

Share on Social Networks: